Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07316062

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.

Official title: A Multi-centre Chart Review Study on the Treatment Patterns and Outcomes of Stage I-III Non-Small Cell Lung Cancer in China

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

3000

Start Date

2026-04-15

Completion Date

2029-04-30

Last Updated

2026-01-05

Healthy Volunteers

No

Locations (1)

Research Site

Beijing, China